Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical screening for Ph-like ALL and the developing role of TKIs.

Hematology. American Society of Hematology. Education Program - 9 Dec 2022

Tran Thai Hoa, Tasian Sarah K

Abstract excerpt

Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) is a common subtype of B-lineage acute lymphoblastic leukemia (B-ALL) with increasing frequency across the age spectrum. Characterized by a kinase-activated gene expression profile and driven by a variety of genetic alterations involving cytokine receptors and kinases, Ph-like ALL is associated with high rates of residual disease and relapse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm, Residual

Share to Philadelphia Chromosome

Share to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Protein Kinase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 36485164
DOI: 10.1182/hematology.2022000357
PMCID: PMC9821133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical screening for Ph-like ALL and the developing role of TKIs.PMID 36485164Read ↗

Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

How I treat Philadelphia chromosome–like acute lymphoblastic leukemia in children, adolescents, and young adultsSemantic proximity Read ↗

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.Semantic proximity Read ↗

Philadelphia chromosome–like acute lymphoblastic leukemiaSemantic proximity Read ↗

Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Semantic proximity Read ↗

Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular LandscapeSemantic proximity Read ↗

Advances in the Genetics and Therapy of Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Advances in the Genetics and Therapy of Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

The biology of Philadelphia chromosome-like ALL.Semantic proximity Read ↗

High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in AdultsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.